Agfa HealthCare Introduces the DR 600 High-Productivity X-ray Room with ZeroForce Technology

Agfa HealthCareAgfa HealthCare will introduce the new DR 600* multi-detector, high-productivity, high-throughput direct radiography (DR) solution at RSNA 2015. With innovative features and ZeroForce Technology, the DR 600 offers excellent speed, precision and comfort. The system shows particular strength in full leg/full spine (FLFS) imaging with it's EasyStitch technology.

Enhanced workflow and throughput
Fully automated, the DR 600 streamlines workflow, increases throughput and enhances the experience of patients and operators alike, even in the busiest imaging environments. Full automation, auto-positioning and auto-tracking allow light, fast and easy operation.

The ZeroForce Technology enables manual movement of the tube head in all directions quickly and with almost zero effort.The MUSICA workflow provides immediate previews that reduce time between exposures and thus deliver a higher rate of throughput. The result is a lower cost per exam and faster patient throughput.

Scalable design and robust components
The DR 600 includes an innovative tube head design with a touch screen control panel featuring a preview image and an integrated soft console on the MUSICA viewing station. Built with solid, factory-quality hardware manufactured at Agfa HealthCare's award-winning factory in Peissenberg, Germany, the DR 600 offers a broad range of customizable options.

The direct image capture capabilities and versatile panel formats allow many different configurations. Each hospital can design the room it needs and migrate to direct radiography seamlessly - whether immediately implementing a full DR solution, or a cassette-based computed radiography (CR) solution that can then evolve to cassette-less DR when the hospital is ready.

Precision MUSICA image processing
The DR 600 comes with Agfa HealthCare's MUSICA gold standard image processing software - the latest intelligent and automated digital radiography image processing software for consistently reliable, high-quality image visualization. Exam independent, MUSICA automatically analyzes the characteristics of each image and optimizes processing parameters - independent of user input and dose deviations. As a result, minimal re- or post-processing is required.

Dose management and potential reduction
The DR 600 comes with a choice of fixed, tethered or wireless detectors, with Cesium Iodide (CsI) or Gadolinium Oxy-Sulphide (GOS) technology. The excellent image quality of the Cesium Iodide offers the potential for significant patient dose reduction[1], with faster availability of images that speeds up workflow and reduces patient waiting times.

With leading-edge Automatic Exposure Control offering high-speed accuracy and collimators with a Dose Area Product meter, the DR 600 can optimize and automatically report doses. Short exposures offered by new dose sensing technology keep dose measurement accurate to the millisecond.

DR Full Leg Full Spine option with EasyStitch technology
The fully motorized wall bucky has vertical tracking with the tube, offering the option of DR Full Leg Full Spine (FLFS) with EasyStitch technology. Based on fully automated single focus technology, EasyStitch minimizes distortions. Angular tracking is available for dedicated exams, while motorized movement of the wall stand and tube head provides accurate stitching capabilities, for high precision in images. An optional table overlay allows you to perform FLFS right on the table.

Speed, precision and comfort
"The DR 600 is designed to offer hospitals the speed, precision and comfort they need for their high-throughput imaging environments," comments Louis Kuitenbrouwer, Vice President Imaging Division, Agfa HealthCare. "It brings together top-of-the-line features and components in a complete and integrated solution that provides high quality images, while maximizing productivity, versatility and ease of use. With the DR 600, everything comes together to produce images, quickly and efficiently, designed for comfort and ease of use for patient and operator alike."

* FDA clearance of the DR 600 is pending

1. Testing with board-certified radiologists has determined that Cesium Bromide (CR) and Cesium Iodide (DR) Detectors, when used with MUSICA image processing, can provide dose reductions of 50 to 60%, compared to traditional Barium Fluoro Bromide CR systems. Contact Agfa HealthCare for more details.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,865 million euro in 2013.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2013 were 1,160 million euro.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...